Cannabis wine enters our lives
On this blog we have talked about cannabis beers made with barley and marijuana oil, and also beers made with 100% cannabis. We have told you about the tendency of millennials to consume more cannabis…
Iberian Peninsula express shipping
0€ Orders over 60€
*6€ orders under 59€
East, West, South Europe express shipping
0€ Orders over 150€
*18€ orders under 149€
North Europe express shipping
0€ Orders over 160€
*20€ orders under 159€
Ireland, Norway, UK normal shipping
0€ Orders over 60€
*6€ orders under 59€
Rest of the world normal shipping
0€ Orders over 180€
*25€ orders under 179€
Shipping costs can be confirmed in your shopping cart.
For additional shipping methods, please reach out through info@kannabia.com.
*Website protected by SSL.
**Not available in all regions.
*Your coupon will be sent via email.
*Should you have any question, comment or feedback, please do not hesitate to contact us.
It is estimated that epilepsy affects between 0.6% and 0.75% of the dog population, although it is not known exactly what the prevalence is. “This disease consists of a brain disorder that causes a series of uncontrollable physical reactions in dogs” we read in the press release issued by the UNLP. These reactions can be convulsions, muscular rigidity, relaxation of the sphincter, abundant salivation, vomiting, disorientation or lack of stimulus response.
Participating In this study by the UNPL were dogs with idiopathic epilepsy for whom classical antiepileptic treatments have failed to work. All were diagnosed with this disease through clinical analysis and magnetic resonance imaging (MRI). This is a multi-centre study with animals from the Faculty as well as other veterinary centres.
“The initiative is presented as a complement to the classic medications, with the idea of reducing the dose of traditional antiepileptic drugs throughout treatment, which in many cases are not effective,” explained Fabiana Landoni, project director, in a press release issued by the National University of La Plata.
Two cannabis oils prepared by the Faculty of Exact Sciences were used, vía the Centre for Environmental Research (CIM-UNLP-CONICET) and under the coordination of researcher Darío Andrinolo. One of these products had a high dominance of THC and the other a balanced THC and CBD content.
What is idiopathic epilepsy? It is a type of epilepsy that is so named when there is no identifiable cause to differentiate it from a secondary or symptomatic type, as a consequence of traumatisms, brain tumours or genetic malformations.
What process was followed? An experimental design “pre-test / post-test”, which compares the state, frequency and intensity of seizures, before and after receiving treatment with cannabis oils.
Six dogs took part in this study and two of them have already exceeded two months of treatment. Three of these dogs had severe epileptic episodes before starting the new treatment, with more than four seizures per day.
“In some cases they reached the ‘epilepticus status’ that is, seizures lasting more than an hour,” said Fabiana Landoni, project director.
“All the dogs were receiving traditional antiepileptic medication, which included more than one drug at high doses, without improving clinical symptoms.Thanks to cannabis oil therapy, the seizures were significantly reduced, and two of them were even able to reduce the dose of at least one of the classic antiepileptics by 25%” she revealed.
What is the current situation of these dogs? Three of them, with more than 2 months of treatment, have evolved in a very positive way, having had no episode since they began with the oils. Two of them have reduced the dose of at least one of the classic antiepileptics they took by 25%.
This project using oils in dogs with refractory idiopathic epilepsy is an example of the interdisciplinary work in the field of scientific research of the UNLP, working together with researchers from the Chair of General and Clinical Pharmacology of the Faculty of Veterinary Sciences and of the Faculty of Exact Sciences.
Kannabia Seeds Company sells to its customers a product collection, a souvenir. We cannot and we shall not give growing advice since our product is not intended for this purpose.
Kannabia accept no responsibility for any illegal use made by third parties of information published. The cultivation of cannabis for personal consumption is an activity subject to legal restrictions that vary from state to state. We recommend consultation of the legislation in force in your country of residence to avoid participation in any illegal activity.